---
title: "Beijing Tongrentang Co.,Ltd (600085.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600085.SH.md"
symbol: "600085.SH"
name: "Beijing Tongrentang Co.,Ltd"
industry: "Pharmaceuticals"
datetime: "2026-04-15T17:27:02.381Z"
locales:
  - [en](https://longbridge.com/en/quote/600085.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600085.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600085.SH.md)
---

# Beijing Tongrentang Co.,Ltd (600085.SH)

## Company Overview

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [gf.tongrentang.com](https://gf.tongrentang.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-15T04:30:13.000Z

**Overall: C (0.45)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 71 / 222 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -7.21% |  |
| Net Profit YoY | -22.07% |  |
| P/B Ratio | 2.82 |  |
| Dividend Ratio | 1.78% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 38372139695.86 |  |
| Revenue | 17218543165.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 8.86% | B |
| Profit Margin | 6.89% | B |
| Gross Margin | 42.24% | B |
| Revenue YoY | -7.21% | D |
| Net Profit YoY | -22.07% | D |
| Total Assets YoY | -1.85% | D |
| Net Assets YoY | 2.28% | C |
| Cash Flow Margin | 226.41% | A |
| OCF YoY | -7.21% | D |
| Turnover | 0.56 | C |
| Gearing Ratio | 30.18% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Beijing Tongrentang Co.,Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-7.21%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-22.07%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.82",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.78%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "38372139695.86",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "17218543165.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "8.86%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "6.89%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "42.24%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-7.21%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-22.07%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.85%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.28%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "226.41%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-7.21%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.56",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "30.18%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 32.34 | 76/222 | 33.45 | 32.58 | 31.83 |
| PB | 2.82 | 126/222 | 3.64 | 3.49 | 3.10 |
| PS (TTM) | 2.23 | 38/222 | 2.69 | 2.55 | 2.34 |
| Dividend Yield | 1.78% | 67/222 | 2.77% | 1.81% | 1.54% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | B | B | A |
| 02 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 03 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 04 | Salubris (002294.SZ) | B | C | C | A | B | B |
| 05 | Haisco (002653.SZ) | B | B | B | B | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-12T16:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 71% |
| Overweight | 1 | 14% |
| Sell | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 28.05 |
| Highest Target | 47.00 |
| Lowest Target | 27.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/600085.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/600085.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/600085.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/600085.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**